1956 related articles for article (PubMed ID: 8435203)
1. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
[TBL] [Abstract][Full Text] [Related]
2. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
3. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
4. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
[TBL] [Abstract][Full Text] [Related]
5. Positivity for HLA DR1 is associated with basal cell carcinoma in renal transplant patients in southern Brazil.
de Carvalho AV; Bonamigo RR; da Silva CM; Pinto AC
Int J Dermatol; 2012 Dec; 51(12):1448-53. PubMed ID: 23171011
[TBL] [Abstract][Full Text] [Related]
6. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
7. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
8. Comparison of skin cancers in liver and renal transplant recipients: Results of a prospective study in an Australian tertiary referral centre.
Ge L; Chee SN; Robledo KP; Lowe P
Australas J Dermatol; 2018 Nov; 59(4):291-296. PubMed ID: 29292515
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
[TBL] [Abstract][Full Text] [Related]
10. Characterization of monocyte-derived dendritic cells from immunosuppressed renal transplant recipients with and without squamous cell carcinomas.
Sandvik LF; Volchenkov R; Jonsson R; Appel S
Scand J Immunol; 2013 Sep; 78(3):291-7. PubMed ID: 23790073
[TBL] [Abstract][Full Text] [Related]
11. HLA and multiple skin carcinomas.
Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
[TBL] [Abstract][Full Text] [Related]
12. Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls.
Sandvik LF; Skarstein K; Krynitz B; Volchenkov R; Sviland L; Leivestad T; Jonsson R; Appel S
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2128-35. PubMed ID: 25845701
[TBL] [Abstract][Full Text] [Related]
13. T6+ and HLA-DR+ cell numbers in epidermis of immunosuppressed renal transplant recipients.
Kelly G; Scheibner A; Murray E; Sheil R; Tiller D; Horvath J
J Cutan Pathol; 1987 Aug; 14(4):202-6. PubMed ID: 3114340
[TBL] [Abstract][Full Text] [Related]
14. Skin cancer surveillance in renal transplant recipients: re-evaluation of U.K. practice and comparison with Australian experience.
Garg S; Carroll RP; Walker RG; Ramsay HM; Harden PN
Br J Dermatol; 2009 Jan; 160(1):177-9. PubMed ID: 18798841
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
Sommerer C; Hartschuh W; Enk A; Meuer S; Zeier M; Giese T
Clin Transplant; 2008; 22(5):549-54. PubMed ID: 18394001
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigens and multiple basal cell carcinomas.
Rompel R; Petres J; Kaupert K; Müller-Eckhardt G
Recent Results Cancer Res; 1995; 139():297-302. PubMed ID: 7597298
[TBL] [Abstract][Full Text] [Related]
18. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Ng JC; Cumming S; Leung V; Chong AH
Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
[TBL] [Abstract][Full Text] [Related]
19. p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours.
Khorshid SM; Glover MT; Churchill L; McGregor JM; Proby CM
J Cutan Pathol; 1996 Jun; 23(3):229-33. PubMed ID: 8793657
[TBL] [Abstract][Full Text] [Related]
20. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
